["Titanium","Platinum","Gold","Silver","Super","Star","Other"]
[1000,500,250,100,50,25,0]
["Titanium","Platinum","Gold","Silver","Super","Star","Other"]
[5000,2500,1000,500,250,100,0]
["Titanium","Platinum","Gold","Silver","Super","Star","Other"]
[10000,5000,2500,1000,500,250,0]
    • Home
    • Event Overview
      • Event Details
      • Mission
      • Gallery
      • Travel
      • Safety
      • FAQ
    • Get Involved
      • Ride
      • Donate
      • Corporate Involvement
      • Event Weekend Volunteers
      • Other Athletic Events
    • Resources
      • Share Your Why
      • Fundraising Tools & Tips
      • Fundraising Incentives
      • Important Dates
      • Community
      • Training Info
      • Meet Your Staff Partners
    • Register
    • Participant Dashboard
  • Two wheels, one goal: a world without blood cancer.


    From October 22-25, 2026, riders from across the country will come together in Greenville, SC for Velo Palmetto, Blood Cancer United's premier multi-day cycling and fundraising experience. Riders choose one, two, or three days of cycling, with multiple course and distance options offered each day, welcoming everyone to ride through the rolling foothills of the Blue Ridge Mountains, and know that every pedal helps advance our mission to cure blood cancer.


    Together, we're more than cyclists, we're changemakers. Every dollar raised and every mile ridden fuels progress toward cures and brings hope to those facing blood cancer.

    When you register for Blood Cancer United's Velo Palmetto, you are signing up for a fundraising mission first, and a bike ride second.



  • Our Mission: Find a cure for blood cancer.

    Blood Cancer United is at the forefront of the fight to cure cancer. Compared to other blood cancer nonprofits, Blood Cancer United is the largest funder of cutting-edge research to advance cures. We have invested nearly $1.8 billion in research. We are leaders in advancing breakthroughs in immunotherapy, genomics and personalized medicine. This research saves lives. These revolutionary new treatments originally discovered through blood cancer research are now being tested in clinical trials for other cancers.

    Our Goal: Raise $750,000 as a team.

  • Tell Me More
  • Interested in learning more? Click the button above, tell us how to best reach you and we'll be in touch!

  • Thank you to our sponsors

  • In Kind Partners


  • Follow us

    •  
    •  
    •  
    •  
    •  
    •  
    •  

    The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

    The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.

    Footer

    • Privacy Policy
    • Security
    • Copyright
    • Link Policy
    • Disclaimer
    • Public Disclosure
    • Fundraising Disclosure
    • Refund Policy
    • Work for LLS
    • Contact Us
    • En Espanol
    • LLS Canada

    The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.

    Learn More About LLS
    • Refund Policy
    • Privacy Policy
    • Security
    • Disclaimer
    • Link Policy
    • Copyright